You deserve to be heard
Dryness, painful intimacy and changes in tissue comfort can have different causes—and there are different treatments.
- Locations
- (352) 353-0092
- (352) 353-0416
- Email Us
- Text Us
Vaginal or vulvar changes after childbirth, with aging, or around menopause can affect comfort and confidence. At Cleveland Health Center, we offer an individualized consultation and discuss options—including BTL EMFEMME 360, a specialized radiofrequency technology for internal and external intimate tissue treatment—when appropriate.
Personalized care for patients in Central Florida and those traveling from elsewhere.
Dryness, painful intimacy and changes in tissue comfort can have different causes—and there are different treatments.
EMFEMME 360 delivers controlled radiofrequency warmth using applicators designed for specific internal or external tissue areas.
Prescription vaginal therapies, pelvic-floor care, gynecologic evaluation, or other approaches may be more appropriate.
It can be difficult to bring up intimate concerns. Some women notice changes in comfort, sensitivity or tissue feel after childbirth or around menopause, while others have discomfort that makes intimacy stressful.
EMFEMME 360 is a BTL radiofrequency (RF) device designed to deliver controlled heating to internal or external intimate tissues using specialized applicators. RF energy is converted into warmth within tissue; proposed effects include changes in local tissue structure and collagen remodeling.
It is not a diagnostic test or a proven universal treatment for vaginal dryness, urinary leakage or sexual dysfunction. A careful consultation is the first step to deciding whether to consider RF at all.
These common concerns deserve a careful diagnosis. Some can be treated with well-established medical therapies; RF is not the automatic first choice.
These symptoms may result from menopause-related changes, skin disorders, infection, medications or other causes. Diagnosis comes before RF discussion.
Pain with sex deserves evaluation for tissue changes, pelvic-floor overactivity, infection and other treatable conditions.
Patients may notice tissue or support changes after pregnancy, childbirth or with age. We explain what RF can and cannot reasonably address.
An external applicator may be considered for selected treatment goals after a private exam and discussion.
We consider hormonal, psychological, relationship, medication and pelvic factors rather than assuming a device will solve every concern.
These symptoms require a separate bladder and pelvic-floor evaluation. BTL EMSELLA pelvic floor therapy may be a more directly relevant option for certain patients.
EMFEMME 360 uses circumferential radiofrequency heating. BTL's applicators are designed for internal or external treatment, with controlled delivery of warmth rather than cutting or injecting tissue.
During a session, an appropriate applicator is used by a trained clinician following device-specific instructions. Patients commonly describe a warming sensation. Treatment time and number of sessions depend on the applicator, actual device model, and treatment plan; we do not promise a fixed duration or outcome.
It is important to distinguish EMFEMME 360 from EMSELLA. EMFEMME uses radiofrequency to warm tissue; EMSELLA uses electromagnetic energy to contract pelvic-floor muscles. They are different technologies with different intended roles.
We begin with what has changed, what bothers you, and what you hope to improve.
Depending on symptoms, this may include a focused medical history, medication review, examination or gynecology referral.
We discuss accepted treatments, RF evidence limitations, potential risks, costs, and whether the service matches your goals.
If appropriate, the procedure is performed according to the device protocol; aftercare and reassessment are explained before you leave.
| Option | Main purpose | Clinical role |
|---|---|---|
| BTL EMFEMME 360 (radiofrequency) | Controlled thermal energy applied to selected intimate tissues. | Selective, emerging application; discuss uncertain symptom benefit and device-related risks. |
| Vaginal moisturizers and lubricants | Reduce dryness and friction. | Common first approaches when symptoms are mild or related to intercourse. |
| Local vaginal hormonal treatment | Addresses estrogen-related genitourinary symptoms when appropriate. | Evidence-supported treatment for selected menopause-related vaginal symptoms. |
| Pelvic-floor therapy / EMSELLA | Targets pelvic-floor function and urinary symptoms through different approaches. | For leakage or pelvic muscle symptoms, depending on diagnosis. |
Radiofrequency treatment usually involves localized warmth. Temporary tenderness, irritation or other side effects are possible. More serious adverse events—including burns, scarring and persistent pain—have been reported with vaginal energy-based devices, so proper selection and informed consent matter.
The FDA has not approved energy-based procedures for vaginal rejuvenation or for treating menopausal symptoms, urinary incontinence, or sexual dysfunction. High-quality evidence of the benefits of vaginal RF for those outcomes remains limited. At CHC, we explain this before treatment rather than promising results.
It is an intimate-area radiofrequency technology with internal and external applicators designed to deliver controlled warmth to selected tissue.
No. EMFEMME 360 uses radiofrequency heating; EMSELLA uses electromagnetic muscle stimulation for pelvic-floor muscle rehabilitation and urinary incontinence.
Evidence for vaginal energy-based treatment of menopausal symptoms remains uncertain. We review evidence-supported options, including moisturizers and appropriately prescribed vaginal therapies, before considering RF.
No energy-based device has FDA approval for vaginal rejuvenation, treatment of menopause-related vaginal symptoms, urinary incontinence or sexual dysfunction.
Patients often describe warmth. Pain or significant discomfort should be reported immediately, and treatment may be stopped or adjusted.
The number of sessions varies by device configuration, indication and clinical protocol. We explain the plan after your consultation and confirm the exact CHC device model.
Recovery instructions vary. Some patients may resume normal activities quickly, but we provide procedure-specific guidance and warning signs rather than guaranteeing zero downtime.
Possible risks include irritation, pain, burns, scarring and persistent discomfort. Safety screening, skilled application and informed consent are essential.
Urinary leakage may have different causes. For muscle-related incontinence, a dedicated pelvic-floor evaluation and EMSELLA discussion may be more appropriate; RF is not an FDA-approved urinary incontinence treatment.
Anyone with unexplained bleeding, infection, significant pelvic pain, pregnancy, implants, medical conditions affecting healing or new/worsening symptoms needs careful assessment or referral first.
Our goal is to listen carefully, identify the most likely cause of your symptoms, and explain the benefits and limitations of available treatments. We welcome patients from The Villages, Wildwood, throughout Florida, other states, and internationally.
Learn about Florian Gegaj, MD and Cleveland Health Center’s approach to individualized medical care.
Clinical recommendations change over time. CHC clinicians review eligibility and the current evidence for each patient.
These concerns may overlap with sexual wellness, but they deserve their own evaluation. Learn more about our separate Urinary Incontinence & Pelvic Floor Therapy service and BTL EMSELLA treatment.